GHP Investment Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-36,997
Closed -$1.7M 290
2015
Q2
$1.7M Buy
36,997
+8,640
+30% +$310K 0.42% 64
2015
Q1
$999K Buy
28,357
+2,675
+10% +$90.5K 0.26% 107
2014
Q4
$825K Buy
25,682
+1,550
+6% +$44.8K 0.23% 123
2014
Q3
$677K Buy
24,132
+370
+2% +$11.3K 0.2% 130
2014
Q2
$718K Buy
23,762
+2,790
+13% +$77K 0.21% 123
2014
Q1
$581K Buy
20,972
+920
+5% +$24.1K 0.19% 135
2013
Q4
$512K Buy
20,052
+2,528
+14% +$77.9K 0.17% 140
2013
Q3
$524K Buy
17,524
+1,586
+10% +$44.1K 0.19% 133
2013
Q2
$458K Buy
+15,938
New +$439K 0.18% 132

Other funds holding BRLI

GHP Investment Advisors's BRLI Position: Q3 2015 in Review

GHP Investment Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 36,997 shares — an estimated $1.7M sold.

GHP Investment Advisors first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $1.7M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • GHP Investment Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • GHP Investment Advisors sold 36,997 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.7M.
  • GHP Investment Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • GHP Investment Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $1.7M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on GHP Investment Advisors's 13F filing for Q3 2015, filed 2 Nov 2015.